Could a tiny skin shot replace the big rabies needle?

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy volunteers aged \>4 years * Able to comply with the research process and provide informed consent * Able to attend all the scheduled visits and comply with the trial procedures * Medical history and clinical examination demonstrating that the subject is healthy * Women willing to follow any method of contraception throughout the duration of the study. Exclusion Criteria: * Subjects participating in other clinical trials in the 4 weeks preceding the first trial vaccination dose * Subjects with a history of previous rabies vaccination (either pre- or post-exposure prophylaxis) * Subjects with a history of receiving Rabies immunoglobulin (Ig (human/equine) prior to the study * Subjects with a fever (≥37.2°C) or any moderate or severe acute illnesses or active infections on the day of vaccination * History of systemic hypersensitivity to any component included in the vaccine or a history of adverse events as a reaction to previous experimental vaccine studies * History of receiving any immunoglobulin, blood, or blood-based product in the last 3 months or planning to donate blood in the following 3 months, which may interfere with the immune response * Screened as positive for HBsAg, Anti-HCV, and anti-HIV * Subjects receiving any vaccine at least 4 weeks prior to enrolment or expected to receive any vaccine 4 weeks after the administration of the trial vaccine. * Lactating women or pregnant women as detected by the urine hCG strip test. * History of alcohol or any substance abuse (benzodiazepines, methamphetamines, opioids, cannabinoids, cocaine, barbiturates) within 1 year * Subjects with congenital or acquired immunodeficiency or subjected to short- or long-term corticosteroid or immunosuppressive therapy * Thrombocytopenia, bleeding disorders, or anticoagulants used during the 3 weeks prior to trial vaccination to avoid intramuscular haemorrhage * Any major psychiatric disorder such as schizophrenia, major depressive disorder, severe anxiety disorder, etc. * History of cardiac arrhythmias, such as bradycardia, tachycardia, supraventricular tachycardia (SVT), ventricular tachycardia (VT), ventricular fibrillation (VF), atrial fibrillation (AF), etc., as assessed by the electrocardiogram report * History of renal insufficiency or dialysis * Any immunosuppressive disorder, such as cancers, multiple myeloma (MM), various autoimmune diseases, etc. * Participants with clinically significant or abnormal laboratory parameters (serum creatinine, SGPT, AST, serum electrolytes) in the opinion of the investigator. * Any condition that presents an unacceptable risk of injury, as assessed by the site investigator * Subjects planning to have surgery in the 3 months preceding the completion of the project * Subjects concurrently using anti-malarial drugs * Any condition that, in the researcher's opinion, would jeopardize the safety or rights of the subject or prevent the subject from completing the procedures of the study protocol * Subjects exposed to any rabid animal bite in the 4 weeks preceding the commencement of the study. * Subjects with Type I or Type II Diabetes, as assessed by Random Blood Sugar level. * All research facility staff directly participating in this study, including their immediate family and relatives.